Kristagen is a peptide complex that contains amino acids that contribute to the normalization of the immune system.
A clinical study has demonstrated the efficiency of Kristagen in comprehensive prevention and treatment of patients with dysfunction of the immune system after infectious diseases, radiation and chemotherapy, emotional stress, effects of the various adverse factors (including environmental, climatic, geo-pathogenic factors and ionizing radiation) and to support the immune system in elderly patients.
Experimental study of the biological properties of Kristagen showed that its application not only improves the individual cellular and tissue homeostasis of the immune cells, but also normalizes the immune system. Course admission of Kristagen has shwoed a noticeable improvement in the overall condition of the human organism and, above all, has reduced the severity of asthenic syndrome, characteristic of secondary immunodeficiency. In patients with purulent-inflammatory complications after surgery we found a significant increase in the activity of tissue enzymes, as evidence by the accelerated epithelization of wounds. In patients with the effects from radiation and chemotherapy whilst taking Kristagena we have been observing accelerated normalization of immune parameters of peripheral blood, improvement of overall health and reduction of frequency of infectious complications.
Kristagen is well tolerated, with no identified side effects, complications, contraindications and drug dependence.
Adults: from 1 to 2 capsules, once or twice a day during food intake. Duration: 10-30 days. It is advised to repeat the procedure after 4-6 months.
Peptide complex AC-6 (proline, glutamic acid, aspartic acid). Other ingredients: microcrystalline cellulose (E460),beetroot sugar, lactose, starch, Tween-80. As an additional source of peptides.